2024
Performance of contemporary cardiovascular risk stratification scores in Brazil: an evaluation in the ELSA-Brasil study
Camargos A, Barreto S, Brant L, Ribeiro A, Dhingra L, Aminorroaya A, Bittencourt M, Figueiredo R, Khera R. Performance of contemporary cardiovascular risk stratification scores in Brazil: an evaluation in the ELSA-Brasil study. Open Heart 2024, 11: e002762. PMID: 38862252, PMCID: PMC11168182, DOI: 10.1136/openhrt-2024-002762.Peer-Reviewed Original ResearchConceptsPooled Cohort EquationsELSA-BrasilRisk scoreCardiovascular diseaseCVD eventsCommunity-based cohort studyArea under the receiver operating characteristic curveCVD risk scoreELSA-Brasil studyIncident CVD eventsMiddle-income countriesAdjudicated CVD eventsCardiovascular disease riskCVD scoreCohort EquationsNational guidelinesRisk stratification scoresWhite womenAge/sex groupsCohort studyProspective cohortLMICsSex/race groupsHigher incomeRisk discrimination
2021
Prevalence and trends of coronary artery disease risk factors and their effect on age of diagnosis in patients with established coronary artery disease: Tehran Heart Center (2005–2015)
Hosseini K, Mortazavi S, Sadeghian S, Ayati A, Nalini M, Aminorroaya A, Tavolinejad H, Salarifar M, Pourhosseini H, Aein A, Jalali A, Bozorgi A, Mehrani M, Kamangar F. Prevalence and trends of coronary artery disease risk factors and their effect on age of diagnosis in patients with established coronary artery disease: Tehran Heart Center (2005–2015). BMC Cardiovascular Disorders 2021, 21: 477. PMID: 34607557, PMCID: PMC8491372, DOI: 10.1186/s12872-021-02293-y.Peer-Reviewed Original ResearchConceptsCAD risk factorsRisk factorsTehran Heart CenterOpium useDisease risk factorsEffect of opium useCoronary artery disease risk factorsArtery disease risk factorsMiddle-income countriesYears earlier ageHigher risk of CADHeart CenterCAD diagnosisCross-sectional studyPublic health challengeArtery diseaseAssociated with higher riskBody-mass indexRisk of CADConventional CAD risk factorsAge of CAD onsetLipid profile componentsTraditional risk factorsHypertension prevalenceAge of diagnosis
2020
Effects of Angiotensin Receptor Blockers (ARBs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected COVID-19
Soleimani A, Kazemian S, Saleh S, Aminorroaya A, Shajari Z, Hadadi A, Talebpour M, Sadeghian H, Payandemehr P, Sotoodehnia M, Bahreini M, Najmeddin F, Heidarzadeh A, Zivari E, Ashraf H. Effects of Angiotensin Receptor Blockers (ARBs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected COVID-19. American Journal Of Hypertension 2020, 33: 1102-1111. PMID: 32920644, PMCID: PMC7543264, DOI: 10.1093/ajh/hpaa149.Peer-Reviewed Original ResearchConceptsAngiotensin II receptor blockersAngiotensin-converting enzyme inhibitorsIn-hospital outcomesAcute kidney injuryClinically suspected COVID-19Severe COVID-19Receptor blockersEffects of angiotensin receptor blockersWorld Health Organization interim guidanceBenefits of angiotensin-converting enzyme inhibitorsIn-hospital outcomes of patientsAssociated with poor in-hospital outcomesFollowed-up patientsPoor in-hospital outcomesOutcomes of patientsAngiotensin receptor blockersII receptor blockersRetrospective observational studyIn-hospital complicationsIncomplete medical recordsRisk of mortalityClinical suspicionInvasive ventilationHypertensive patientsKidney injuryRecommendations of the current guidelines for implantable cardioverter-defibrillator implantation in patients with hypertrophic cardiomyopathy: Debate still exists
Aminorroaya A, Vasheghani-Farahani A, Masoudkabir F, Roayaei P. Recommendations of the current guidelines for implantable cardioverter-defibrillator implantation in patients with hypertrophic cardiomyopathy: Debate still exists. Journal Of Interventional Cardiac Electrophysiology 2020, 60: 1-7. PMID: 32712900, DOI: 10.1007/s10840-020-00837-4.Peer-Reviewed Original ResearchConceptsSudden cardiac deathImplantable cardioverter-defibrillatorHypertrophic cardiomyopathySudden cardiac death risk stratificationEuropean Society of Cardiology guidelinesPrimary prevention implantable cardioverter-defibrillatorRisk stratification of patientsAmerican College of Cardiology Foundation/American Heart AssociationImplantable cardioverter-defibrillator implantationHigh-risk patientsStratification of patientsImplantation of primary prevention implantable cardioverter-defibrillatorsCardioverter-defibrillator implantationCardiology guidelinesRisk patientsVentricular arrhythmiasClinical outcomesCardiac deathCardioverter-defibrillatorHeart AssociationAmerican CollegePrimary preventionPatientsCare practitionersEuropean Society
2019
Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results from the GBD Study 2016.
Ebrahimi H, Amini E, Pishgar F, Moghaddam S, Nabavizadeh B, Rostamabadi Y, Aminorroaya A, Fitzmaurice C, Farzadfar F, Nowroozi M, Black P, Daneshmand S. Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results from the GBD Study 2016. Journal Of Urology 2019, 201: 893-901. PMID: 30676477, DOI: 10.1097/ju.0000000000000025.Peer-Reviewed Original ResearchConceptsMortality-to-incidence ratioAge-standardized ratesBladder cancer burdenCancer burdenIncident casesAge-standardized incidence rateGlobal Burden of Disease StudyBladder cancer risk factorsBurden of Disease StudyCancer deathCancer incident casesComparative risk assessment frameworkBurden of bladder cancerCancer risk factorsAge-standardized incidenceStandardized incidence rateDisability adjusted life yearsStandard rateStandard life expectancyVital registration systemsHigher fasting plasma glucoseBladder cancer deathYears of lifeHigher fasting glucoseBladder cancer